STOCK TITAN
  1. Home
  2. Sec-filings
  3. PLXS
  4. [Form 4] Plexus Corp Insider Trading Activity

Plexus (PLXS) Insider Sale: 1,500 Shares Sold Under 10b5-1 Plan

Filing Impact
(High)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Todd P. Kelsey, President & CEO and a director of Plexus Corp (PLXS), reported a sale of company stock under a pre-established 10b5-1 plan. On 09/02/2025 he disposed of 1,500 shares of Plexus common stock at $134.54 per share. After the reported sale, Mr. Kelsey beneficially owned 70,714 shares, held directly. The filing states the transactions were made pursuant to a Rule 10b5-1 plan adopted on August 16, 2024, and the Form 4 was signed on 09/03/2025 by an attorney-in-fact.

Positive

  • Transaction disclosed under a Rule 10b5-1 plan, which clarifies that the sale was preplanned and reduces concerns about opportunistic timing
  • Form 4 filed promptly and signed (reported transaction 09/02/2025; filing executed 09/03/2025), meeting disclosure requirements

Negative

  • None.

Insights

TL;DR: Insider sale via a pre-established 10b5-1 plan reduces holdings modestly and follows routine disclosure practices.

The Form 4 documents a routine, rule-compliant disposition by the company’s President & CEO under a Rule 10b5-1 trading plan adopted August 16, 2024. The sale of 1,500 shares at $134.54 is modest relative to typical CEO holdings and the remaining direct holding is reported as 70,714 shares. The filing is properly executed by an attorney-in-fact and provides the required explanatory remark that the sale was pursuant to the 10b5-1 plan, which helps limit concerns about opportunistic timing. There is no indication in this filing of acquisitions, option exercises, or other derivative transactions.

TL;DR: Transaction is informationally neutral; small-scale sale under a previously adopted plan, no new material disclosures for investors.

The reported disposition does not introduce new operational or financial information about Plexus Corp. The size of the sale (1,500 shares) and the retained position (70,714 shares) are explicitly stated, and the use of a 10b5-1 plan suggests the transaction timing is pre-determined. For investors, this is a standard insider disclosure that maintains transparency but is not material by itself.

Insider Kelsey Todd P.
Role President & CEO
Sold 1,500 shs ($202K)
Type Security Shares Price Value
Sale Common Stock, $.01 par value 1,500 $134.54 $202K
Holdings After Transaction: Common Stock, $.01 par value — 70,714 shares (Direct)
Footnotes (1)
  1. [object Object]
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
 Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Kelsey Todd P.
(Last) (First) (Middle)
ONE PLEXUS WAY
(Street)
NEENAH WI 54956
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
PLEXUS CORP [ PLXS ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
President & CEO
3. Date of Earliest Transaction (Month/Day/Year)
09/02/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock, $.01 par value 09/02/2025 S(1) 1,500 D $134.54 70,714 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Shares were sold pursuant to a Rule 10b5-1 plan adopted on August 16, 2024.
Remarks:
/s/ Todd P. Kelsey, by Kate A. Gitter, Attorney-in-Fact 09/03/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What did PLXS insider Todd P. Kelsey sell?

He sold 1,500 shares of Plexus Corp common stock at $134.54 per share on 09/02/2025.

Was the sale by PLXS insider part of a trading plan?

Yes. The sale was made pursuant to a Rule 10b5-1 plan adopted on August 16, 2024.

How many PLXS shares does Todd P. Kelsey own after the sale?

70,714 shares beneficially owned following the reported transaction, held directly.

When was the Form 4 for the PLXS transaction signed?

09/03/2025, signed by Todd P. Kelsey via an attorney-in-fact, Kate A. Gitter.

Does the Form 4 report any option exercises or derivative transactions?

No. Table II for derivative securities shows no entries; only a non-derivative sale is reported.